Protein-based nanoparticles for therapeutic nucleic acid delivery.

Feyisayo Eweje1, Michelle L Walsh2, Kiran Ahmad3

  • 1Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA; Harvard and MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA; Harvard/MIT MD-PhD Program, Boston, MA, USA, 02115; Wyss Institute of Biologically Inspired Engineering, Harvard University, Boston, MA, 02115, USA.

Biomaterials
|January 5, 2024
PubMed
Summary

Protein nanoparticles offer a biodegradable and functionalizable platform for delivering nucleic acid therapies. This review explores their potential and challenges for therapeutic applications.